510(k) device
BrainsWay Deep TMS System
Brainsway , Ltd. · Transcranial Magnetic Stimulator (OBP, Class II) · First FDA decision Jan 7, 2013, newest Nov 7, 2025DepressionOCD, PTSD and other psychiatric conditions
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
510(k) pathway
Device trials
177
Naming "Deep TMS"
MAUDE reports
14
Brand "Deep TMS", since 2015
PubMed studies
129
Mentioning "Deep TMS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing BrainsWay Deep TMS System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
K251391 · Decided Nov 7, 2025 · 186 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
K251449 · Decided Sep 13, 2025 · 127 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
- Deep TMS System510(k)
K222196 · Decided May 31, 2024 · 679 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcranial Magnetic StimulationLocal determinationIn effectL33398Wellpoint FederalUpdated Jul 16, 2026
- Transcranial Magnetic StimulationProposed local determinationProposedDL33398National Government Services, Inc.Updated Mar 27, 2026
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL34641WPS Insurance CorporationUpdated Mar 20, 2026
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL37086Noridian Healthcare Solutions, LLCUpdated Aug 6, 2025
- Repetitive Transcranial Magnetic Stimulation (rTMS) in AdultsLocal determinationIn effectL34869Palmetto GBAUpdated Jan 7, 2025
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL36469CGS Administrators, LLCUpdated May 30, 2024
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34522First Coast Service Options, Inc.Updated Oct 21, 2022
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34998Novitas Solutions, Inc.Updated Oct 21, 2022
Clinical trials
Device studies on ClinicalTrials.gov that name "Deep TMS", any status and sponsor, newest update first.
- Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)Pivotal-lookingRecruiting
BrainswayNot on our public-company list
NCT07216872 · 186 participants (planned) · Start Nov 7, 2025 · Primary completion Nov 1, 2027
Device: Deep TMS (DTMS); Sham (No Treatment) · For: Alcohol Use Disorder; Alcoholism; Alcohol Abuse and 3 more
Sites: Tuscaloosa, Alabama; La Jolla, California; West Palm Beach, Florida · 11 sites in all
- Using Artificial Intelligence to Detect Early Signs of Alzheimer's Disease in People With Memory ConcernsNot yet recruiting
IRCCS San RaffaeleAcademic, hospital or other
NCT07652931 · 300 participants (planned) · Start Dec 1, 2026 · Primary completion Aug 1, 2028
Device: High-frequency Transcranial Magnetic Stimulation (TMS) · For: Subjective Cognitive Decline; Alzheimer Disease; Mild Cognitive Impairment and 1 more
Sites: Milan, Italy
- Phase-Locked Accelerated Intermittent Theta Burst Stimulation for Treatment-Resistant DepressionCompleted
Cheng-Hsin General HospitalAcademic, hospital or other
NCT07930000 · 54 participants · Start May 22, 2024 · Primary completion Apr 15, 2026
Device: Phase-Locked Accelerated Intermittent Theta Burst Stimulation; Random-Phase Accelerated Intermittent Theta Burst Stimulation · For: Treatment Resistant Depression (TRD)
Sites: Taipei, Taiwan
174 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Deep TMS", and for the whole product code for context.
This brand
14 reports: 0 malfunction, 14 injury, 0 death
Whole product code OBP
337 reports: 9 malfunction, 323 injury, 2 death
Newest reports for this brand
3010300-2025-20504 · Received Dec 16, 2025 · Event dated Jul 24, 2025
Device type: Transcranial Magnetic Stimulator (OBP)
Device problem as coded: Use of Device Problem
Patient problem as coded: Convulsion/Seizure
- DEEP TMS SYSTEMInjury
3010300912-2025-19948 · Received Jul 10, 2025 · Event dated Jun 16, 2025
Device type: Transcranial Magnetic Stimulator (OBP)
Device problem as coded: Improper or Incorrect Procedure or Method
Patient problem as coded: Convulsion/Seizure
3010300912-2025-19110 · Received Jun 10, 2025 · Event dated May 2, 2025
Device type: Transcranial Magnetic Stimulator (OBP)
Device problem as coded: Improper or Incorrect Procedure or Method
Patient problem as coded: Convulsion/Seizure
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Deep TMS"[tiab]. The summary above synthesizes these.
- Deep TMS H7 Coil: Features, Applications & Future.
Harmelech T, Roth Y, Tendler A · Expert Rev Med Devices · 2021Review
- Deep TMS: A comprehensive summary of adverse events from five multicenter trials.
Tendler A, Gersner R, Roth Y, et al. · Brain Stimul · 2023Letter, Research Support, Non-U.S. Gov't
- Clinical efficacy of deep transcranial magnetic stimulation (dTMS) in psychiatric and cognitive disorders: A systematic review.
Di Passa AM, Prokop-Millar S, Yaya H, et al. · J Psychiatr Res · 2024Systematic Review, Research Support, Non-U.S. Gov't
- Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder.
Harmelech T, Roth Y, Tendler A · Psychiatr Clin North Am · 2023Review
- Deep TMS H1 Coil treatment for depression: Results from a large post marketing data analysis.
Tendler A, Goerigk S, Zibman S, et al. · Psychiatry Res · 2023Clinical Trial, Phase IV, Research Support, Non-U.S. Gov't
- Does 18 Hz deep TMS benefit a different subgroup of depressed patients relative to 10 Hz rTMS? The role of the individual alpha frequency.
Voetterl H, Alyagon U, Middleton VJ, et al. · Eur Neuropsychopharmacol · 2024Research Support, Non-U.S. Gov't
- Efficacy of Deep TMS with the H1 Coil for Anxious Depression.
Pell GS, Harmelech T, Zibman S, et al. · J Clin Med · 2022
- Safety and efficacy of Deep TMS for adolescent depression based on large real-world data analysis.
Roth Y, Tendler A, Pell GS, et al. · Psychiatry Res · 2025Research Support, Non-U.S. Gov't
- Moderators of the response to deep TMS for smoking addiction.
Gersner R, Barnea-Ygael N, Tendler A · Front Psychiatry · 2022
- Deep TMS add-on treatment for intractable Tourette syndrome: A feasibility study.
Bloch Y, Arad S, Levkovitz Y · World J Biol Psychiatry · 2016
- Does deep TMS really works for smoking cessation? A prospective, double blind, randomized, sham controlled study.
Bellini BB, Scholz JR, Abe TO, et al. · Prog Neuropsychopharmacol Biol Psychiatry · 2024Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Repetitive deep TMS in alcohol dependent patients halts progression of white matter changes in early abstinence.
Selim MK, Harel M, De Santis S, et al. · Psychiatry Clin Neurosci · 2024Randomized Controlled Trial
Other devices of this type
Also filed under product code OBP.
- NeuroStar TMS Therapy SystemNeuronetics, Inc. · 510(k) 2022
- Apollo TMS Therapy SystemMag & More GmbH · 510(k) 2026
- MagVita TMS Therapy w/MagPro R20Tonica Elektronik A/S · 510(k) 2017
- NeuroStar Advanced Therapy System (All previously cleared models)Neuronetics, Inc. · 510(k) 2024
- Magstim Horizon 3.0 TMS Therapy SystemMagstim Company, Ltd. · 510(k) 2023
- HORIZON TMS Therapy System with NavigationMagstim Company, Ltd. · 510(k) 2019
- Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)Nexstim Oyj · 510(k) 2026
- MagVenture TMS Therapy SystemTonica Elektronik A/S · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.